跳至主要内容
临床试验/ITMCTR2200005751
ITMCTR2200005751尚未招募1 期

Efficacy and safety of acupuncture at Different depths of Qugu Acupoint in the treatment of benign prostatic hyperplasia: a randomized controlled trial

Xiyuan Hospital of China Academy of Chinese Medical Sciences0 个研究点开始时间: 待定最近更新:
适应症

试验速览

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
50 至 80(—)
性别
Male

入选标准

  • (1)It meets the diagnostic criteria of BPH and has been clearly diagnosed by a specialist;
  • (2)The age ranges from 50 to 80;
  • (3)Voluntary subjects who sign informed consent voluntarily.

排除标准

  • (1) Unable to communicate unobstructed;
  • (2) Associated with urethritis, acute prostatitis, urinary calculi and other diseases;
  • (3) Complicated with neurogenic bladder, bladder neck fibrosis, urethral stricture and other diseases;
  • (4) Patients with neurological diseases or diabetes that affect urination function;
  • (5) Hyperplasia of prostate complicated with malignant wasting diseases such as prostate cancer and tuberculosis;
  • (6) Patients with serious diseases such as liver and kidney insufficiency and other heart and lung diseases and blood diseases;
  • (7) Patients taking anticoagulants for a long time and patients with severe anemia;
  • (8) Patients with upper urinary tract obstruction and hydronephrosis and impaired renal function found by B-ultrasound;
  • (9) Have been using drugs that may affect bladder function or are receiving BPH drugs;
  • (10) B ultrasound or CT found excessive prostatic hyperplasia, protruding too much bladder, affecting acupuncture operators;
  • (11) B ultrasound or CT found that residual urine in the bladder was more than 100ml or too much, which affected the acupuncture operator.

研究者

相似试验